Cargando…
Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers
Drugs are serious but underestimated causative agents of interstitial lung disease (ILD). Both cytotoxic and immune mechanisms may be involved in drug-induced ILD (DI-ILD). We aimed to investigate whether polymorphisms of relevant CYP enzymes involved in the metabolization of tamsulosin might explai...
Autores principales: | Jessurun, Naomi T., Wijnen, Petal A., Bast, Aalt, van Puijenbroek, Eugène P., Bekers, Otto, Drent, Marjolein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215842/ https://www.ncbi.nlm.nih.gov/pubmed/32316326 http://dx.doi.org/10.3390/ijms21082770 |
Ejemplares similares
-
Drug-induced comorbidities in patients with sarcoidosis
por: Drent, Marjolein, et al.
Publicado: (2022) -
Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity
por: Jessurun, Naomi T., et al.
Publicado: (2021) -
VKORC1 and CYP2C9 Polymorphisms: A Case Report in a Dutch Family with Pulmonary Fibrosis
por: Wijnen, Petal, et al.
Publicado: (2019) -
Prevalence of interstitial and other lung diseases on Aruba
por: Deenstra, Duco, et al.
Publicado: (2017) -
Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis
por: de Brouwer, Bart, et al.
Publicado: (2018)